nodes	percent_of_prediction	percent_of_DWPC	metapath
Chenodeoxycholic acid—UGT2B7—Epirubicin—sarcoma	0.332	0.608	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Thiotepa—sarcoma	0.098	0.18	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Mitoxantrone—sarcoma	0.0421	0.0772	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Vincristine—sarcoma	0.029	0.0531	CbGbCtD
Chenodeoxycholic acid—NR1H4—skull—sarcoma	0.0267	0.172	CbGeAlD
Chenodeoxycholic acid—CYP3A4—Etoposide—sarcoma	0.0266	0.0487	CbGbCtD
Chenodeoxycholic acid—CYP27A1—leg—sarcoma	0.0189	0.122	CbGeAlD
Chenodeoxycholic acid—CYP27A1—forelimb—sarcoma	0.0187	0.121	CbGeAlD
Chenodeoxycholic acid—CYP3A4—Doxorubicin—sarcoma	0.0181	0.0332	CbGbCtD
Chenodeoxycholic acid—CYP27A1—hindlimb—sarcoma	0.0169	0.109	CbGeAlD
Chenodeoxycholic acid—CYP27A1—appendage—sarcoma	0.0145	0.0931	CbGeAlD
Chenodeoxycholic acid—NR1H4—hematopoietic system—sarcoma	0.00589	0.0379	CbGeAlD
Chenodeoxycholic acid—NR1H4—connective tissue—sarcoma	0.00567	0.0365	CbGeAlD
Chenodeoxycholic acid—CYP27A1—myometrium—sarcoma	0.00499	0.0322	CbGeAlD
Chenodeoxycholic acid—CYP27A1—seminal vesicle—sarcoma	0.00451	0.029	CbGeAlD
Chenodeoxycholic acid—CYP27A1—hematopoietic system—sarcoma	0.00428	0.0276	CbGeAlD
Chenodeoxycholic acid—CYP27A1—connective tissue—sarcoma	0.00413	0.0266	CbGeAlD
Chenodeoxycholic acid—CYP27A1—skin of body—sarcoma	0.00373	0.024	CbGeAlD
Chenodeoxycholic acid—CYP27A1—cardiac atrium—sarcoma	0.00325	0.021	CbGeAlD
Chenodeoxycholic acid—NR1H4—liver—sarcoma	0.00305	0.0197	CbGeAlD
Chenodeoxycholic acid—CYP27A1—lymphoid tissue—sarcoma	0.00302	0.0194	CbGeAlD
Chenodeoxycholic acid—CYP27A1—tendon—sarcoma	0.00284	0.0183	CbGeAlD
Chenodeoxycholic acid—CYP27A1—testis—sarcoma	0.00235	0.0151	CbGeAlD
Chenodeoxycholic acid—NR1H4—lymph node—sarcoma	0.00234	0.0151	CbGeAlD
Chenodeoxycholic acid—CYP27A1—liver—sarcoma	0.00222	0.0143	CbGeAlD
Chenodeoxycholic acid—UGT2B7—testis—sarcoma	0.00208	0.0134	CbGeAlD
Chenodeoxycholic acid—UGT2B7—liver—sarcoma	0.00197	0.0127	CbGeAlD
Chenodeoxycholic acid—CYP27A1—lymph node—sarcoma	0.0017	0.011	CbGeAlD
Chenodeoxycholic acid—CYP3A4—hematopoietic system—sarcoma	0.00103	0.00666	CbGeAlD
Chenodeoxycholic acid—CYP3A4—liver—sarcoma	0.000536	0.00345	CbGeAlD
Chenodeoxycholic acid—Hypotension—Etoposide—sarcoma	0.000293	0.000979	CcSEcCtD
Chenodeoxycholic acid—Gastritis—Doxorubicin—sarcoma	0.000293	0.000979	CcSEcCtD
Chenodeoxycholic acid—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000292	0.000975	CcSEcCtD
Chenodeoxycholic acid—Dysuria—Epirubicin—sarcoma	0.000289	0.000966	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Thiotepa—sarcoma	0.000288	0.000965	CcSEcCtD
Chenodeoxycholic acid—Upper respiratory tract infection—Epirubicin—sarcoma	0.000287	0.00096	CcSEcCtD
Chenodeoxycholic acid—Asthma—Doxorubicin—sarcoma	0.000286	0.000956	CcSEcCtD
Chenodeoxycholic acid—Influenza—Doxorubicin—sarcoma	0.000286	0.000956	CcSEcCtD
Chenodeoxycholic acid—Dysphagia—Doxorubicin—sarcoma	0.000286	0.000956	CcSEcCtD
Chenodeoxycholic acid—Pollakiuria—Epirubicin—sarcoma	0.000285	0.000954	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Vincristine—sarcoma	0.000285	0.000953	CcSEcCtD
Chenodeoxycholic acid—Photosensitivity reaction—Epirubicin—sarcoma	0.000282	0.000943	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Etoposide—sarcoma	0.000281	0.000941	CcSEcCtD
Chenodeoxycholic acid—Weight increased—Epirubicin—sarcoma	0.000281	0.00094	CcSEcCtD
Chenodeoxycholic acid—Pancreatitis—Doxorubicin—sarcoma	0.00028	0.000937	CcSEcCtD
Chenodeoxycholic acid—Weight decreased—Epirubicin—sarcoma	0.000279	0.000935	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Etoposide—sarcoma	0.000279	0.000934	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Etoposide—sarcoma	0.000279	0.000932	CcSEcCtD
Chenodeoxycholic acid—Angina pectoris—Doxorubicin—sarcoma	0.000278	0.000931	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Mitoxantrone—sarcoma	0.000277	0.000928	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Vincristine—sarcoma	0.000277	0.000928	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Thiotepa—sarcoma	0.000277	0.000928	CcSEcCtD
Chenodeoxycholic acid—Pneumonia—Epirubicin—sarcoma	0.000277	0.000926	CcSEcCtD
Chenodeoxycholic acid—Infestation NOS—Epirubicin—sarcoma	0.000275	0.000921	CcSEcCtD
Chenodeoxycholic acid—Infestation—Epirubicin—sarcoma	0.000275	0.000921	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Dactinomycin—sarcoma	0.000275	0.000921	CcSEcCtD
Chenodeoxycholic acid—Rash—Thiotepa—sarcoma	0.000275	0.00092	CcSEcCtD
Chenodeoxycholic acid—Bronchitis—Doxorubicin—sarcoma	0.000275	0.000919	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Thiotepa—sarcoma	0.000275	0.000919	CcSEcCtD
Chenodeoxycholic acid—Headache—Thiotepa—sarcoma	0.000273	0.000914	CcSEcCtD
Chenodeoxycholic acid—Rash—Dactinomycin—sarcoma	0.000273	0.000913	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Etoposide—sarcoma	0.000272	0.000911	CcSEcCtD
Chenodeoxycholic acid—Renal failure—Epirubicin—sarcoma	0.000271	0.000905	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Etoposide—sarcoma	0.00027	0.000905	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Mitoxantrone—sarcoma	0.00027	0.000904	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Etoposide—sarcoma	0.00027	0.000903	CcSEcCtD
Chenodeoxycholic acid—Jaundice—Epirubicin—sarcoma	0.000268	0.000898	CcSEcCtD
Chenodeoxycholic acid—Constipation—Etoposide—sarcoma	0.000268	0.000896	CcSEcCtD
Chenodeoxycholic acid—Pain—Etoposide—sarcoma	0.000268	0.000896	CcSEcCtD
Chenodeoxycholic acid—Urinary tract infection—Epirubicin—sarcoma	0.000268	0.000895	CcSEcCtD
Chenodeoxycholic acid—Conjunctivitis—Epirubicin—sarcoma	0.000268	0.000895	CcSEcCtD
Chenodeoxycholic acid—Dysuria—Doxorubicin—sarcoma	0.000267	0.000894	CcSEcCtD
Chenodeoxycholic acid—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000266	0.000888	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Vincristine—sarcoma	0.000265	0.000885	CcSEcCtD
Chenodeoxycholic acid—Sweating—Epirubicin—sarcoma	0.000264	0.000883	CcSEcCtD
Chenodeoxycholic acid—Pollakiuria—Doxorubicin—sarcoma	0.000264	0.000883	CcSEcCtD
Chenodeoxycholic acid—Haematuria—Epirubicin—sarcoma	0.000263	0.000878	CcSEcCtD
Chenodeoxycholic acid—Photosensitivity reaction—Doxorubicin—sarcoma	0.000261	0.000872	CcSEcCtD
Chenodeoxycholic acid—Hepatobiliary disease—Epirubicin—sarcoma	0.00026	0.000871	CcSEcCtD
Chenodeoxycholic acid—Weight increased—Doxorubicin—sarcoma	0.00026	0.00087	CcSEcCtD
Chenodeoxycholic acid—Epistaxis—Epirubicin—sarcoma	0.00026	0.000869	CcSEcCtD
Chenodeoxycholic acid—Nausea—Thiotepa—sarcoma	0.000259	0.000867	CcSEcCtD
Chenodeoxycholic acid—Weight decreased—Doxorubicin—sarcoma	0.000259	0.000865	CcSEcCtD
Chenodeoxycholic acid—Sinusitis—Epirubicin—sarcoma	0.000258	0.000864	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Etoposide—sarcoma	0.000258	0.000864	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Mitoxantrone—sarcoma	0.000258	0.000862	CcSEcCtD
Chenodeoxycholic acid—Nausea—Dactinomycin—sarcoma	0.000257	0.00086	CcSEcCtD
Chenodeoxycholic acid—Pneumonia—Doxorubicin—sarcoma	0.000256	0.000857	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Etoposide—sarcoma	0.000256	0.000857	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Vincristine—sarcoma	0.000256	0.000855	CcSEcCtD
Chenodeoxycholic acid—Infestation NOS—Doxorubicin—sarcoma	0.000255	0.000852	CcSEcCtD
Chenodeoxycholic acid—Infestation—Doxorubicin—sarcoma	0.000255	0.000852	CcSEcCtD
Chenodeoxycholic acid—Renal failure—Doxorubicin—sarcoma	0.00025	0.000838	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Etoposide—sarcoma	0.000249	0.000832	CcSEcCtD
Chenodeoxycholic acid—Haemoglobin—Epirubicin—sarcoma	0.000248	0.000831	CcSEcCtD
Chenodeoxycholic acid—Jaundice—Doxorubicin—sarcoma	0.000248	0.000831	CcSEcCtD
Chenodeoxycholic acid—Rhinitis—Epirubicin—sarcoma	0.000248	0.000829	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Etoposide—sarcoma	0.000248	0.000828	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Etoposide—sarcoma	0.000248	0.000828	CcSEcCtD
Chenodeoxycholic acid—Conjunctivitis—Doxorubicin—sarcoma	0.000248	0.000828	CcSEcCtD
Chenodeoxycholic acid—Urinary tract infection—Doxorubicin—sarcoma	0.000248	0.000828	CcSEcCtD
Chenodeoxycholic acid—Haemorrhage—Epirubicin—sarcoma	0.000247	0.000827	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Vincristine—sarcoma	0.000246	0.000822	CcSEcCtD
Chenodeoxycholic acid—Pharyngitis—Epirubicin—sarcoma	0.000245	0.000821	CcSEcCtD
Chenodeoxycholic acid—Sweating—Doxorubicin—sarcoma	0.000244	0.000817	CcSEcCtD
Chenodeoxycholic acid—Urinary tract disorder—Epirubicin—sarcoma	0.000244	0.000817	CcSEcCtD
Chenodeoxycholic acid—Rash—Vincristine—sarcoma	0.000244	0.000816	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Vincristine—sarcoma	0.000244	0.000815	CcSEcCtD
Chenodeoxycholic acid—Oedema peripheral—Epirubicin—sarcoma	0.000244	0.000814	CcSEcCtD
Chenodeoxycholic acid—Haematuria—Doxorubicin—sarcoma	0.000243	0.000813	CcSEcCtD
Chenodeoxycholic acid—Connective tissue disorder—Epirubicin—sarcoma	0.000243	0.000812	CcSEcCtD
Chenodeoxycholic acid—Urethral disorder—Epirubicin—sarcoma	0.000242	0.00081	CcSEcCtD
Chenodeoxycholic acid—Headache—Vincristine—sarcoma	0.000242	0.00081	CcSEcCtD
Chenodeoxycholic acid—Hepatobiliary disease—Doxorubicin—sarcoma	0.000241	0.000806	CcSEcCtD
Chenodeoxycholic acid—Epistaxis—Doxorubicin—sarcoma	0.00024	0.000804	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Mitoxantrone—sarcoma	0.000239	0.000801	CcSEcCtD
Chenodeoxycholic acid—Sinusitis—Doxorubicin—sarcoma	0.000239	0.000799	CcSEcCtD
Chenodeoxycholic acid—Visual impairment—Epirubicin—sarcoma	0.000238	0.000797	CcSEcCtD
Chenodeoxycholic acid—Rash—Mitoxantrone—sarcoma	0.000237	0.000794	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Mitoxantrone—sarcoma	0.000237	0.000794	CcSEcCtD
Chenodeoxycholic acid—Headache—Mitoxantrone—sarcoma	0.000236	0.000789	CcSEcCtD
Chenodeoxycholic acid—Eye disorder—Epirubicin—sarcoma	0.000231	0.000773	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Etoposide—sarcoma	0.000231	0.000772	CcSEcCtD
Chenodeoxycholic acid—Tinnitus—Epirubicin—sarcoma	0.00023	0.000771	CcSEcCtD
Chenodeoxycholic acid—Haemoglobin—Doxorubicin—sarcoma	0.00023	0.000769	CcSEcCtD
Chenodeoxycholic acid—Nausea—Vincristine—sarcoma	0.00023	0.000768	CcSEcCtD
Chenodeoxycholic acid—Cardiac disorder—Epirubicin—sarcoma	0.000229	0.000767	CcSEcCtD
Chenodeoxycholic acid—Rhinitis—Doxorubicin—sarcoma	0.000229	0.000767	CcSEcCtD
Chenodeoxycholic acid—Haemorrhage—Doxorubicin—sarcoma	0.000229	0.000765	CcSEcCtD
Chenodeoxycholic acid—Pharyngitis—Doxorubicin—sarcoma	0.000227	0.000759	CcSEcCtD
Chenodeoxycholic acid—Urinary tract disorder—Doxorubicin—sarcoma	0.000226	0.000755	CcSEcCtD
Chenodeoxycholic acid—Oedema peripheral—Doxorubicin—sarcoma	0.000225	0.000754	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Etoposide—sarcoma	0.000225	0.000752	CcSEcCtD
Chenodeoxycholic acid—Connective tissue disorder—Doxorubicin—sarcoma	0.000225	0.000752	CcSEcCtD
Chenodeoxycholic acid—Angiopathy—Epirubicin—sarcoma	0.000224	0.00075	CcSEcCtD
Chenodeoxycholic acid—Urethral disorder—Doxorubicin—sarcoma	0.000224	0.00075	CcSEcCtD
Chenodeoxycholic acid—Nausea—Mitoxantrone—sarcoma	0.000224	0.000748	CcSEcCtD
Chenodeoxycholic acid—Immune system disorder—Epirubicin—sarcoma	0.000223	0.000747	CcSEcCtD
Chenodeoxycholic acid—Mediastinal disorder—Epirubicin—sarcoma	0.000223	0.000745	CcSEcCtD
Chenodeoxycholic acid—Chills—Epirubicin—sarcoma	0.000222	0.000742	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Etoposide—sarcoma	0.000222	0.000741	CcSEcCtD
Chenodeoxycholic acid—Arrhythmia—Epirubicin—sarcoma	0.000221	0.000739	CcSEcCtD
Chenodeoxycholic acid—Visual impairment—Doxorubicin—sarcoma	0.00022	0.000737	CcSEcCtD
Chenodeoxycholic acid—Alopecia—Epirubicin—sarcoma	0.000218	0.000731	CcSEcCtD
Chenodeoxycholic acid—Malnutrition—Epirubicin—sarcoma	0.000215	0.00072	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Etoposide—sarcoma	0.000214	0.000717	CcSEcCtD
Chenodeoxycholic acid—Eye disorder—Doxorubicin—sarcoma	0.000214	0.000715	CcSEcCtD
Chenodeoxycholic acid—Tinnitus—Doxorubicin—sarcoma	0.000213	0.000713	CcSEcCtD
Chenodeoxycholic acid—Cardiac disorder—Doxorubicin—sarcoma	0.000212	0.00071	CcSEcCtD
Chenodeoxycholic acid—Flatulence—Epirubicin—sarcoma	0.000212	0.000709	CcSEcCtD
Chenodeoxycholic acid—Tension—Epirubicin—sarcoma	0.000211	0.000706	CcSEcCtD
Chenodeoxycholic acid—Nervousness—Epirubicin—sarcoma	0.000209	0.000699	CcSEcCtD
Chenodeoxycholic acid—Back pain—Epirubicin—sarcoma	0.000208	0.000696	CcSEcCtD
Chenodeoxycholic acid—Angiopathy—Doxorubicin—sarcoma	0.000208	0.000694	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Etoposide—sarcoma	0.000207	0.000693	CcSEcCtD
Chenodeoxycholic acid—Muscle spasms—Epirubicin—sarcoma	0.000207	0.000692	CcSEcCtD
Chenodeoxycholic acid—Immune system disorder—Doxorubicin—sarcoma	0.000207	0.000691	CcSEcCtD
Chenodeoxycholic acid—Mediastinal disorder—Doxorubicin—sarcoma	0.000206	0.000689	CcSEcCtD
Chenodeoxycholic acid—Chills—Doxorubicin—sarcoma	0.000205	0.000686	CcSEcCtD
Chenodeoxycholic acid—Arrhythmia—Doxorubicin—sarcoma	0.000204	0.000683	CcSEcCtD
Chenodeoxycholic acid—Alopecia—Doxorubicin—sarcoma	0.000202	0.000676	CcSEcCtD
Chenodeoxycholic acid—Ill-defined disorder—Epirubicin—sarcoma	0.0002	0.000668	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Etoposide—sarcoma	0.000199	0.000666	CcSEcCtD
Chenodeoxycholic acid—Malnutrition—Doxorubicin—sarcoma	0.000199	0.000666	CcSEcCtD
Chenodeoxycholic acid—Anaemia—Epirubicin—sarcoma	0.000199	0.000665	CcSEcCtD
Chenodeoxycholic acid—Rash—Etoposide—sarcoma	0.000198	0.000661	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Etoposide—sarcoma	0.000197	0.00066	CcSEcCtD
Chenodeoxycholic acid—Headache—Etoposide—sarcoma	0.000196	0.000656	CcSEcCtD
Chenodeoxycholic acid—Flatulence—Doxorubicin—sarcoma	0.000196	0.000656	CcSEcCtD
Chenodeoxycholic acid—Tension—Doxorubicin—sarcoma	0.000195	0.000653	CcSEcCtD
Chenodeoxycholic acid—Malaise—Epirubicin—sarcoma	0.000194	0.000649	CcSEcCtD
Chenodeoxycholic acid—Nervousness—Doxorubicin—sarcoma	0.000193	0.000647	CcSEcCtD
Chenodeoxycholic acid—Vertigo—Epirubicin—sarcoma	0.000193	0.000647	CcSEcCtD
Chenodeoxycholic acid—Syncope—Epirubicin—sarcoma	0.000193	0.000645	CcSEcCtD
Chenodeoxycholic acid—Leukopenia—Epirubicin—sarcoma	0.000193	0.000644	CcSEcCtD
Chenodeoxycholic acid—Back pain—Doxorubicin—sarcoma	0.000193	0.000644	CcSEcCtD
Chenodeoxycholic acid—Muscle spasms—Doxorubicin—sarcoma	0.000191	0.00064	CcSEcCtD
Chenodeoxycholic acid—Palpitations—Epirubicin—sarcoma	0.00019	0.000636	CcSEcCtD
Chenodeoxycholic acid—Loss of consciousness—Epirubicin—sarcoma	0.000189	0.000633	CcSEcCtD
Chenodeoxycholic acid—Cough—Epirubicin—sarcoma	0.000188	0.000628	CcSEcCtD
Chenodeoxycholic acid—Convulsion—Epirubicin—sarcoma	0.000186	0.000624	CcSEcCtD
Chenodeoxycholic acid—Nausea—Etoposide—sarcoma	0.000186	0.000622	CcSEcCtD
Chenodeoxycholic acid—Hypertension—Epirubicin—sarcoma	0.000186	0.000621	CcSEcCtD
Chenodeoxycholic acid—Ill-defined disorder—Doxorubicin—sarcoma	0.000185	0.000618	CcSEcCtD
Chenodeoxycholic acid—Anaemia—Doxorubicin—sarcoma	0.000184	0.000616	CcSEcCtD
Chenodeoxycholic acid—Myalgia—Epirubicin—sarcoma	0.000183	0.000613	CcSEcCtD
Chenodeoxycholic acid—Arthralgia—Epirubicin—sarcoma	0.000183	0.000613	CcSEcCtD
Chenodeoxycholic acid—Chest pain—Epirubicin—sarcoma	0.000183	0.000613	CcSEcCtD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000182	0.000609	CcSEcCtD
Chenodeoxycholic acid—Discomfort—Epirubicin—sarcoma	0.000181	0.000605	CcSEcCtD
Chenodeoxycholic acid—Malaise—Doxorubicin—sarcoma	0.00018	0.000601	CcSEcCtD
Chenodeoxycholic acid—Dry mouth—Epirubicin—sarcoma	0.000179	0.000599	CcSEcCtD
Chenodeoxycholic acid—Vertigo—Doxorubicin—sarcoma	0.000179	0.000598	CcSEcCtD
Chenodeoxycholic acid—Syncope—Doxorubicin—sarcoma	0.000179	0.000597	CcSEcCtD
Chenodeoxycholic acid—Leukopenia—Doxorubicin—sarcoma	0.000178	0.000596	CcSEcCtD
Chenodeoxycholic acid—Confusional state—Epirubicin—sarcoma	0.000177	0.000592	CcSEcCtD
Chenodeoxycholic acid—Palpitations—Doxorubicin—sarcoma	0.000176	0.000589	CcSEcCtD
Chenodeoxycholic acid—Oedema—Epirubicin—sarcoma	0.000176	0.000587	CcSEcCtD
Chenodeoxycholic acid—Loss of consciousness—Doxorubicin—sarcoma	0.000175	0.000585	CcSEcCtD
Chenodeoxycholic acid—Infection—Epirubicin—sarcoma	0.000174	0.000584	CcSEcCtD
Chenodeoxycholic acid—Cough—Doxorubicin—sarcoma	0.000174	0.000581	CcSEcCtD
Chenodeoxycholic acid—Shock—Epirubicin—sarcoma	0.000173	0.000578	CcSEcCtD
Chenodeoxycholic acid—Convulsion—Doxorubicin—sarcoma	0.000173	0.000577	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Epirubicin—sarcoma	0.000172	0.000576	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Epirubicin—sarcoma	0.000172	0.000575	CcSEcCtD
Chenodeoxycholic acid—Hypertension—Doxorubicin—sarcoma	0.000172	0.000575	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Epirubicin—sarcoma	0.000171	0.000573	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Epirubicin—sarcoma	0.000171	0.000571	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Epirubicin—sarcoma	0.00017	0.000568	CcSEcCtD
Chenodeoxycholic acid—Arthralgia—Doxorubicin—sarcoma	0.00017	0.000567	CcSEcCtD
Chenodeoxycholic acid—Chest pain—Doxorubicin—sarcoma	0.00017	0.000567	CcSEcCtD
Chenodeoxycholic acid—Myalgia—Doxorubicin—sarcoma	0.00017	0.000567	CcSEcCtD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000168	0.000563	CcSEcCtD
Chenodeoxycholic acid—Discomfort—Doxorubicin—sarcoma	0.000167	0.00056	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Epirubicin—sarcoma	0.000167	0.00056	CcSEcCtD
Chenodeoxycholic acid—Dry mouth—Doxorubicin—sarcoma	0.000166	0.000554	CcSEcCtD
Chenodeoxycholic acid—Hypotension—Epirubicin—sarcoma	0.000164	0.000549	CcSEcCtD
Chenodeoxycholic acid—Confusional state—Doxorubicin—sarcoma	0.000164	0.000548	CcSEcCtD
Chenodeoxycholic acid—Oedema—Doxorubicin—sarcoma	0.000162	0.000544	CcSEcCtD
Chenodeoxycholic acid—Infection—Doxorubicin—sarcoma	0.000161	0.00054	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00016	0.000535	CcSEcCtD
Chenodeoxycholic acid—Shock—Doxorubicin—sarcoma	0.00016	0.000535	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Doxorubicin—sarcoma	0.000159	0.000533	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Doxorubicin—sarcoma	0.000159	0.000532	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Epirubicin—sarcoma	0.000159	0.000531	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Doxorubicin—sarcoma	0.000159	0.00053	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Doxorubicin—sarcoma	0.000158	0.000528	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Epirubicin—sarcoma	0.000158	0.000527	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Doxorubicin—sarcoma	0.000157	0.000525	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Epirubicin—sarcoma	0.000157	0.000524	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Epirubicin—sarcoma	0.000156	0.000522	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Doxorubicin—sarcoma	0.000155	0.000518	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Epirubicin—sarcoma	0.000155	0.000517	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Epirubicin—sarcoma	0.000153	0.000511	CcSEcCtD
Chenodeoxycholic acid—Hypotension—Doxorubicin—sarcoma	0.000152	0.000508	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Epirubicin—sarcoma	0.000152	0.000507	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Epirubicin—sarcoma	0.000151	0.000506	CcSEcCtD
Chenodeoxycholic acid—Pain—Epirubicin—sarcoma	0.00015	0.000502	CcSEcCtD
Chenodeoxycholic acid—Constipation—Epirubicin—sarcoma	0.00015	0.000502	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000148	0.000495	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Doxorubicin—sarcoma	0.000147	0.000492	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Doxorubicin—sarcoma	0.000146	0.000488	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Doxorubicin—sarcoma	0.000145	0.000485	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Epirubicin—sarcoma	0.000145	0.000484	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Doxorubicin—sarcoma	0.000144	0.000483	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Epirubicin—sarcoma	0.000144	0.00048	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Doxorubicin—sarcoma	0.000143	0.000478	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Doxorubicin—sarcoma	0.000141	0.000472	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00014	0.000469	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Doxorubicin—sarcoma	0.00014	0.000469	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Epirubicin—sarcoma	0.00014	0.000467	CcSEcCtD
Chenodeoxycholic acid—Pain—Doxorubicin—sarcoma	0.000139	0.000465	CcSEcCtD
Chenodeoxycholic acid—Constipation—Doxorubicin—sarcoma	0.000139	0.000465	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Epirubicin—sarcoma	0.000139	0.000464	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Epirubicin—sarcoma	0.000139	0.000464	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Doxorubicin—sarcoma	0.000134	0.000448	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Doxorubicin—sarcoma	0.000133	0.000444	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Epirubicin—sarcoma	0.000129	0.000433	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Doxorubicin—sarcoma	0.000129	0.000432	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Doxorubicin—sarcoma	0.000128	0.00043	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Doxorubicin—sarcoma	0.000128	0.00043	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Epirubicin—sarcoma	0.000126	0.000421	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Epirubicin—sarcoma	0.000124	0.000416	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Epirubicin—sarcoma	0.00012	0.000402	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Doxorubicin—sarcoma	0.00012	0.0004	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Doxorubicin—sarcoma	0.000117	0.00039	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Epirubicin—sarcoma	0.000116	0.000388	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Doxorubicin—sarcoma	0.000115	0.000385	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Epirubicin—sarcoma	0.000112	0.000373	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Doxorubicin—sarcoma	0.000111	0.000372	CcSEcCtD
Chenodeoxycholic acid—Rash—Epirubicin—sarcoma	0.000111	0.00037	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Epirubicin—sarcoma	0.000111	0.00037	CcSEcCtD
Chenodeoxycholic acid—Headache—Epirubicin—sarcoma	0.00011	0.000368	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Doxorubicin—sarcoma	0.000107	0.000359	CcSEcCtD
Chenodeoxycholic acid—Nausea—Epirubicin—sarcoma	0.000104	0.000349	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Doxorubicin—sarcoma	0.000103	0.000346	CcSEcCtD
Chenodeoxycholic acid—Rash—Doxorubicin—sarcoma	0.000102	0.000343	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Doxorubicin—sarcoma	0.000102	0.000342	CcSEcCtD
Chenodeoxycholic acid—Headache—Doxorubicin—sarcoma	0.000102	0.00034	CcSEcCtD
Chenodeoxycholic acid—Nausea—Doxorubicin—sarcoma	9.65e-05	0.000323	CcSEcCtD
